Catalyst Wire Dossier Catalyst Wire Dossier

MSC_Apceth

autologous mesenchymal stem cells · Apceth GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSC_Apceth, covering 2015-12-15 to 2015-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia [Phase 1, Phase 2]

See pricing